Orbital apex syndrome (OAS) manifests as multiple cranial nerve palsies caused by an abnormal nerve response to inflammation or other processes. Central diabetes insipidus (CDI) is characterized by deficient synthesis or secretion of antidiuretic hormone. A 62-year-old woman underwent myringotomy for otitis media with effusion. Two months after the procedure, symptoms of hearing loss had not improved, and she underwent left tympanoplasty and mastoidectomy. After surgery, she presented with left ocular pain and visual loss. Neurologic examination revealed ptosis, total ophthalmoplegia, and a relative afferent pupillary defect on the left eye. Magnetic resonance imaging showed an asymmetric contrast-enhancing lesion in the left orbital apex and left cavernous sinus, with adjacent dural thickening and enhancement. OAS was diagnosed, and steroid treatment was started. During the regular follow-up period, she reported polyuria, and CDI was diagnosed. Treatment with intranasal desmopressin 10 μg twice daily was started, and symptoms greatly improved. The mechanism underlying the association of CDI with OAS is unclear, and further research is needed. The present case suggests that polyuria in OAS should alert neurologists and ophthalmologists to possible CDI. (J Nippon Med Sch 2019; 86: 254 257) 
Introduction
The orbital apex is the posterior confluence of the orbit at the craniofacial junction. Many nerves, including the optic nerve, oculomotor nerve, trochlear nerve, abducens nerve, and the ophthalmic branch of the trigeminal nerve, and blood vessels, pass through this structure. Orbital apex syndrome (OAS) is an abnormal response of these nerves to inflammation or other processes, such as infection 1 3 , trauma 4 , neoplasms 5 , and autoimmune disorders. Clinically characteristic symptoms include painful proptosis, ophthalmoplegia, and vision loss. A similar disease-cavernous sinus syndrome-does not affect the optic nerve and thus does not involve optic neuropathy.
Treatment of the causative disease is necessary, and steroids can be used to treat neurological symptoms 6 .
Central diabetes insipidus (CDI) is characterized by deficient synthesis or secretion of antidiuretic hormone (also called arginine vasopressin or AVP) and can cause symptoms of thirst and/or polydipsia, as well as increase in serum sodium and osmolality. Although there are several known causes of CDI 7 , it is idiopathic in approximately 30% to 50% of cases. CDI is associated with destruction of hormone-secreting cells in the hypothalamic nuclei 8 , and most such cases are treated with desmopressin.
In this report, we describe a case of CDI in OAS, which, to our knowledge, has not been previously reported.
Case Report
A 62-year-old woman was referred to the nephrology department for evaluation of polyuria. She had undergone myringotomy for otitis media with effusion at another hospital 1 year previously. For 2 months after that procedure, she was treated with third-generation cephalosporin antibiotics, even though microbiological findings Table   1) . Sellar MRI showed no posterior pituitary bright spot ( Fig. 2) . We diagnosed CDI, and treatment with intranasal desmopressin (10 μg twice daily) resulted in marked improvement in symptoms. 
Discussion
We describe a case of CDI in a patient who initially had only OAS, which suggests that polyuria in OAS should alert neurologists and ophthalmologists of possible CDI. A recent case study reported that fibrosis of the dura mater over the anterior cranial fossa led to CDI, which was diagnosed as a bright spot in the posterior portion of the pituitary gland on gadolinium-enhanced MRI 11 . This imaging finding was reported to be present as a normal finding in 20% to 30% of the population, and in the early stages of CDI 12, 13 . Ultimately, we were unable to determine the exact mechanism underlying the association between CDI and OAS, and further research is thus needed.
